Monday, August 3, 2009

Onglyza: Just Like Januvia--But Worse

Page Added: Onglyza - Just Like Januvia, but Worse

Added review of FDA required Prescribing Information for newly approved DPP-4 inhibitor, Onglyza. Text of page is the same as August 3 Diabetes Update blog post on same topic.
at

No comments:

Post a Comment

Comments posted to promote products or services are deleted. Don't waste our time or yours posting them here.

Note: Only a member of this blog may post a comment.